Latest News and Press Releases

Midatech Pharma PLC ("Midatech" or the "Company") Commencement of First in Human Immunotherapy Study Using Gold Nanoparticle Technology ABINGDON, United Kingdom and OXFORDSHIRE, United Kingdom,...

Midatech Pharma PLC  ("Midatech" or the "Company") Midatech Pharma US Announces Partnership with R-Pharm US to Co-promote Zuplenz ® (ondansetron) oral soluble film and Oravig ®...

Dr. Jim Phillips, Chief Executive Officer and Nick Robbins-Cherry, Finance Director, will host a conference call for analysts at 14.00 BST today. Dial-in details are: UK: +44 1452 555 566, US: +1...

Dr. Jim Phillips, Chief Executive Officer and Nick Robbins-Cherry, Finance Director, will host a conference call for analysts at 14.00 BST today. Dial-in details are: UK: +44 1452 555 566, US: +1 866...

OXFORDSHIRE, United Kingdom, Aug. 10, 2016 (GLOBE NEWSWIRE) --   Midatech Pharma PLC ("Midatech" or the "Company") Trading Update and Notice of Results Midatech Pharma (AIM: MTPH; Nasdaq:...

OXFORDSHIRE, United Kingdom, July 7, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing...

ABINGDON, England, May 18, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...

ABINGDON, England, May 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...

ABINGDON, England, May 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing...

ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...